Correlation Between TC BioPharm and CONMED

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TC BioPharm and CONMED at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TC BioPharm and CONMED into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TC BioPharm plc and CONMED, you can compare the effects of market volatilities on TC BioPharm and CONMED and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TC BioPharm with a short position of CONMED. Check out your portfolio center. Please also check ongoing floating volatility patterns of TC BioPharm and CONMED.

Diversification Opportunities for TC BioPharm and CONMED

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between TCBPW and CONMED is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding TC BioPharm plc and CONMED in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CONMED and TC BioPharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TC BioPharm plc are associated (or correlated) with CONMED. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CONMED has no effect on the direction of TC BioPharm i.e., TC BioPharm and CONMED go up and down completely randomly.

Pair Corralation between TC BioPharm and CONMED

Assuming the 90 days horizon TC BioPharm plc is expected to generate 6.61 times more return on investment than CONMED. However, TC BioPharm is 6.61 times more volatile than CONMED. It trades about -0.02 of its potential returns per unit of risk. CONMED is currently generating about -0.11 per unit of risk. If you would invest  1.40  in TC BioPharm plc on December 26, 2024 and sell it today you would lose (0.80) from holding TC BioPharm plc or give up 57.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy96.67%
ValuesDaily Returns

TC BioPharm plc  vs.  CONMED

 Performance 
       Timeline  
TC BioPharm plc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days TC BioPharm plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
CONMED 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days CONMED has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

TC BioPharm and CONMED Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TC BioPharm and CONMED

The main advantage of trading using opposite TC BioPharm and CONMED positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TC BioPharm position performs unexpectedly, CONMED can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CONMED will offset losses from the drop in CONMED's long position.
The idea behind TC BioPharm plc and CONMED pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals